Details for New Drug Application (NDA): 206214
✉ Email this page to a colleague
The generic ingredient in LORATADINE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 206214
Tradename: | LORATADINE |
Applicant: | Marksans Pharma |
Ingredient: | loratadine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 206214
Suppliers and Packaging for NDA: 206214
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LORATADINE | loratadine | CAPSULE;ORAL | 206214 | ANDA | WALGREENS | 0363-1686 | 0363-1686-07 | 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0363-1686-07) |
LORATADINE | loratadine | CAPSULE;ORAL | 206214 | ANDA | WALGREENS | 0363-1686 | 0363-1686-30 | 3 BLISTER PACK in 1 CARTON (0363-1686-30) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
Approval Date: | Sep 23, 2016 | TE: | RLD: | No |
Complete Access Available with Subscription